Content about Government procurement in the United States

February 20, 2014

Bloomberg on Thursday lined up the potential suitors in discussion with Safeway on a sale of the grocer, citing people with knowledge of the matter.

NEW YORK — Bloomberg on Thursday lined up the potential suitors in discussion with Safeway on a sale of the grocer, citing people with knowledge of the matter. 

Firms CVC Capital Partners and Leonard Green & Partners are among the the interested parties, as is Cerberus Capital Management. 

KKR & Co. bought Safeway in 1986 for about $4.3 billion, according to data compiled by Bloomberg. The retailer went public in 1990.

February 7, 2014

In a report released by the U.S. Government Accountability Office, the GAO found that the total draft federal upper limits amount based on the new formula under the Patient Protection and Affordable Care Act was about 1.4% lower than the total National Average Drug Acquisition Cost amount in aggregate for 1,035 outpatient drugs subject to the FUL in first quarter 2013.

WASHINGTON — In a report publicly released Thursday by the U.S. Government Accountability Office, the GAO found that the total draft federal upper limits amount based on the new formula under the Patient Protection and Affordable Care Act was about 1.4% lower than the total National Average Drug Acquisition Cost amount in aggregate for 1,035 outpatient drugs subject to the FUL in first quarter 2013.

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

January 8, 2014

McKesson is preparing to offer concessions to hedge fund Elliott to save its planned acquisition of Celesio, Reuters reported Wednesday morning, citing people familiar with the deal.

FRANKFURT, Germany — McKesson is preparing to offer concessions to hedge fund Elliott to save its planned acquisition of Celesio, Reuters reported Wednesday morning, citing people familiar with the deal. 

Elliott almost has a large enough stake in Celesio to block the deal and has rejected the $8.3 billion acquisition offer. 

December 19, 2013

Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion.

GÖTEBORG, Sweden — Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for  treating dental erosion.  

The EB24 product is based on hydrogen fluoride highly diluted in water. In studies, the product has shown that it is able to penetrate enamel surfaces and form calcium fluoride resulting in an anti-erosive effect. As such, EB24 works as a protective agent against dental erosion. 

December 9, 2013

A survey of more than 1,000 independent pharmacists finds that acquisition costs for generic drugs have spiked by as much as 1,000% this year.

ALEXANDRIA, Va. — A survey of more than 1,000 independent pharmacists finds that acquisition costs for generic drugs have spiked by as much as 1,000% this year.

December 5, 2013

Mylan has completed its acquisition of the injectables business of Strides Arcolab, a deal worth nearly $2 billion, the drug maker said.

PITTSBURGH — Mylan has completed its acquisition of the injectables business of Strides Arcolab, a deal worth nearly $2 billion, the drug maker said.

Mylan said the acquisition of Agila could cost up to $1.75 billion, including a $250 million contingent consideration. As part of the acquisition, Mylan will gain full commercialization rights for most of Agila's U.S. portfolio of experimental and marketed products, including cancer drugs, as well as significant product rights in Canada, Australia, Brazil, Japan and South Korea.

November 22, 2013

The shareholders of Elan Corp. approved the acquisition of the company by Perrigo Co. at two special meetings.

DUBLIN — The shareholders of Elan Corp. approved the acquisition of the company by Perrigo Co. at two special meetings.

As previously announced earlier this year, Perrigo and Elan entered into an agreement under which the two companies will combine to form New Perrigo, an entirely new company incorporated in Ireland. The closing of the deal remains subject to approval by the Irish High Court and is expected to occur by the end of the year.

October 17, 2013

L’Oréal has announced that it is looking to acquire from Japanese group Shiseido the Decléor and Carita brands.

PARIS — L’Oréal has announced that it is looking to acquire from Japanese group Shiseido the Decléor and Carita brands.

Shiseido has granted L’Oréal exclusive negotiation rights, and an agreement could be signed in the coming weeks following consultation of L’Oréal and Shiseido employee representatives. The acquisition will be submitted to the approval of the relevant regulatory authorities, L’Oréal stated.

September 30, 2013

H. D. Smith on Monday announced full ownership acquisition of Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati.

SPRINGFIELD, Ill. — H. D. Smith on Monday announced full ownership acquisition of Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati. H. D. Smith secured majority representation on Triplefin's board of directors in January 2013 and majority stock ownership interest in May 2013. 

September 4, 2013

Church & Dwight is on the hunt for its next acquisition, after having successfully integrated its gummy vitamin line from Avid Health, chairman and CEO James Craigie told analysts at the 2013 Barclays Back-to-School Consumer Conference held on Tuesday.

BOSTON — Church & Dwight is on the hunt for its next acquisition, after having successfully integrated its gummy vitamin line from Avid Health, chairman and CEO James Craigie told analysts at the 2013 Barclays Back-to-School Consumer Conference held here Tuesday. 

And C&D may be as few as three years away from fielding an OTC product in a gummy format. 

August 6, 2013

Crossmark, a sales and marketing services company, is looking to acquire Marketing Werks, an independent consumer-engagement company.

PLANO, Texas and CHICAGO — Crossmark, a sales and marketing services company, is looking to acquire Marketing Werks, an independent consumer-engagement company.

Terms of the deal, which is expected to close Aug. 31, were not disclosed. The companies stated that the acquisition will have no impact on the day-to-day operations of either company.

August 5, 2013

Revlon is looking to acquire from CVC Capital Partners the beauty company Colomer Group for $660 million, a move that will enable Revlon to expand into the professional salon market.

NEW YORK — Revlon is looking to acquire from CVC Capital Partners the beauty company Colomer Group for $660 million, a move that will enable Revlon to expand into the professional salon market.

The acquisition, which is subject to certain customary conditions and regulatory approvals, is expected to close in the fourth quarter of 2013. Revlon expects to finance the acquisition using funds underwritten by Citigroup Global Markets.

August 2, 2013

Cereal maker Post Holdings will be playing a larger role in the supplement space with its proposed acquisition of Premier Nutrition, makers of the Joint Juice brand.

ST. LOUIS — Cereal maker Post Holdings will be playing a larger role in the supplement space with its proposed acquisition of Premier Nutrition, makers of the Joint Juice brand. The company announced it has signed a definitive agreement to acquire Premier Nutrition on Friday.

July 11, 2013

Actavis and Warner Chilcott announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Warner Chilcott.

PARSIPPANY, N.J. — Actavis and Warner Chilcott on Thursday announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Warner Chilcott. The information request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.  

May 29, 2013

Domtar Corp. announced the signing of a definitive agreement for the acquisition of privately-held Associated Hygienic Products, a manufacturer and supplier of store-brand infant diapers in the United States, from DSG International for $272 million.

MONTREAL — Domtar Corporation on Tuesday announced the signing of a definitive agreement for the acquisition of privately-held Associated Hygienic Products, the largest manufacturer and supplier of store brand infant diapers in the United States, from DSG International for $272 million. The closing of the transaction is expected by the end of the second quarter of 2013, subject to customary closing conditions.

January 8, 2013

The Vitamin Shoppe's proposed acquisition of Super Supplements has been delayed, the company recently announced.

NORTH BERGEN, N.J. — The Vitamin Shoppe's proposed acquisition of Super Supplements has been delayed, the company recently announced. According to the company, the Federal Trade Commission had notified VSI that it is conducting an investigation into the planned acquisition, noting that the investigation will extend beyond Dec. 31, 2012.

October 31, 2012

Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne.

MORRISTOWN, N.J. — Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne. These four products accounted for 70% of all Schiff sales, noted Marijn Dekkers, Bayer CEO, during an analyst call Wednesday morning. "This acquisition will strengthen Bayer's leading OTC business and complement our existing nutritionals business with well-established strong brands," he said. 

September 11, 2012

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

DEERFIELD, Ill. — Walgreens on Monday announced that it has priced an underwritten public offering of senior notes, the net proceeds from which will be used to repay — in full — money that was borrowed to fund the cash consideration in its acquisition of a 45% stake in Alliance Boots and for general corporate purposes, including its previously announced USA Drug acquisition.

The senior notes consist of:

  • $550 million of floating rate notes due 2014;

  • $750 million of 1% notes due 2015;

September 6, 2012

Beauty brand Physicians Formula Holdings has received an unsolicited, nonbinding proposal to acquire all its outstanding shares of common stock at a price of $4.90 per share.

AZUSA, Calif. — Beauty brand Physicians Formula Holdings has received an unsolicited, nonbinding proposal to acquire all its outstanding shares of common stock at a price of $4.90 per share.

The proposal is subject to several conditions, including the completion of due diligence and securing of financing commitments by the third party who submitted the proposal and the negotiation of a mutually acceptable definitive agreement.